The FDA has approved new versions of Pfizer/BioNTech's Comirnaty and Moderna's Spikevax COVID-19 vaccines that target the Omicron KP.2 strain of SARS-CoV-2 which was dominant in the US in recent ...

Shrugging off an earlier phase 3 disappointment, Travere’s Filspari has become the first FDA-approved treatment for rare kidney disease focal segmental glomerulosclerosis (FSGS). The company's already ...

UK biotech Antiverse has raised $9.3 million to accelerate its drug discovery programmes, based on an AI-powered platform for designing antibody-based therapeutics. Cardiff, Wales-based Antiverse's ...

AstraZeneca and Daiichi Sankyo's TROP2-targeting drug Datroway has been approved by the European Commission for some previously untreated patients with metastatic triple-negative breast cancer (TNBC), ...

The patient access system isn't broken because people wanted it to fail. It's broken because it was built for an era where the phone and fax machine were the only universal interfaces, and business ...

IGNYTE showed that patients with confirmed progression on an anti-PD-1-based regimen who received RP1 plus nivolumab had a 34% response rate, with a median duration of 24.8 months, and 15% of them ...

Recordati has received an unsolicited takeover offer from private equity group CVC Capital Partners that, if completed, would delist the pharma group from the Italian stock exchange. The €52-per-share ...

A woman from the Wirral in the UK has become the first patient in the world to receive an experimental cancer vaccine ...

According to a letter (PDF) signed by US Senators Elizabeth Warren (D-Mass), Angela Alsobrooks (D-Md), Richard Blumenthal ...

The once-daily, oral TEC/JAK3 inhibitor has shown efficacy in active and stable nonsegmental vitiligo (NSV) – the most common form of the disease – in which the most common form of vitiligo, ...

2025 is going to be a year of great change. At a macro level, political and geopolitical shifts around the world will reshape relations. Regulation and deregulation may alter processes. And any one of ...

It turns out that the pause on shipments of Sarepta's Duchenne muscular dystrophy (DMD) gene therapy Elevidys over safety concerns has been short-lived. The FDA's request to suspend distribution of ...